NEW YORK (GenomeWeb) – Cancer Genetics reported after the close of the market on Thursday a 15 percent jump in first quarter revenues on strong growth across all of its business segments.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.